The central action of pizotifen

[1]  J. Maj,et al.  The effects of serotonergic and antiserotonergic drugs on the flexor reflex of spinal rat: a proposed model to evaluate the action on the central serotonin receptor , 2005, Journal of Neural Transmission.

[2]  C. Bánki.  Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women , 1978, Archiv für Psychiatrie und Nervenkrankheiten.

[3]  B. Leonard.  Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain , 1974, Psychopharmacologia.

[4]  P. Fell,et al.  The human pharmacology of GB 94 — a new psychotropic agent , 1973, European Journal of Clinical Pharmacology.

[5]  T. Silverstone,et al.  The effect of cyproheptadine on hunger, calorie intake and body weight in man , 2004, Psychopharmacologia.

[6]  J. Maj,et al.  Doxepin as a Blocker of Central Serotonin Receptors , 1977, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[7]  J. Standal,et al.  Pizotifen as an antidepressant , 1977, Acta psychiatrica Scandinavica.

[8]  D. Moura,et al.  Hepatotoxicity of the condensation product of adrenaline with acetaldehyde , 1977, The Journal of pharmacy and pharmacology.

[9]  C. Niemegeers,et al.  Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new 'in vivo' approach: the ATN-test in rats. , 1977, Archives internationales de pharmacodynamie et de therapie.

[10]  Z. Kleinrok,et al.  5-Methoxytryptamine-induced head twitches in rats. , 1977, Polish journal of pharmacology and pharmacy.

[11]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[12]  A. Horita,et al.  Rapid development of tolerance upon central injection of LSD. , 1977, Life sciences.

[13]  G. Scholtysik,et al.  Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). , 1977, Arzneimittel-Forschung.

[14]  A. Coppen,et al.  Mianserin Hydrochloride: A Novel Antidepressant , 1976, British Journal of Psychiatry.

[15]  B. Leonard,et al.  A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain. , 1976, Biochemical pharmacology.

[16]  J. Maj,et al.  The action of compound WA-335 on the central nervous system. , 1976, Archivum immunologiae et therapiae experimentalis.

[17]  J. Fozard.  The animal pharmacology of drugs used in the treatment of migraine , 1975, The Journal of pharmacy and pharmacology.

[18]  J. B. Lassen,et al.  Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. , 1975, European journal of pharmacology.

[19]  C. Niemegeers,et al.  A critical study on RO-4-1284 antagonism in mice. , 1975, Archives internationales de pharmacodynamie et de therapie.

[20]  V. J. Lotti,et al.  INDOLEAMINE ANTAGONISTS: RELATIVE POTENCIES AS INHIBITORS OF TRYPTAMINE‐ AND 5‐HYDROXYTRYPTOPHAN‐EVOKED RESPONSES , 1974, British journal of pharmacology.

[21]  Leonard Be,et al.  The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain. , 1973 .

[22]  H. vanRiezen.  Different central effects of the 5-HT antagonists mianserine and cyproheptadine. , 1972 .

[23]  T. Itil,et al.  Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug). , 1972, Current therapeutic research, clinical and experimental.

[24]  H. van Riezen.  Different central effects of the 5-HT antagonists mianserine and cyproheptadine. , 1972, Archives internationales de pharmacodynamie et de therapie.

[25]  B. Vargaftig,et al.  Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine. , 1971, European journal of pharmacology.

[26]  Hughes Rc,et al.  BC 105 in the prophylaxis of migraine. , 1971 .

[27]  J. B. Foster,et al.  BC 105 in the prophylaxis of migraine. , 1971, Current therapeutic research, clinical and experimental.

[28]  J. Hills.  Planetary Companions of Pulsars , 1970, Nature.

[29]  R. Ryan.  DOUBLE‐BLIND CROSSOVER COMPARISON OF BC‐105, METHYSERGIDE AND PLACEBO IN THE PROHYLAXIS OF MIGRAINE HEADACHE , 1968 .

[30]  J. Yaryura-Tobias,et al.  The action of BC-105 in chronic schizophrenics with depression. , 1968, Current therapeutic research, clinical and experimental.

[31]  R. Ryan.  Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache. , 1968, Headache.

[32]  F. Sicuteri,et al.  An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences. , 1967, International archives of allergy and applied immunology.

[33]  S. Corne,et al.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. , 1963, British journal of pharmacology and chemotherapy.

[34]  D. H. Tedeschi,et al.  The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs. , 1959, The Journal of pharmacology and experimental therapeutics.

[35]  J. C. Burke,et al.  Bioassay of Rauwolfia roots and alkaloids. , 1957, The Journal of pharmacology and experimental therapeutics.

[36]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[37]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, Federation proceedings.

[38]  J. Pickering,et al.  The Action of , 1922 .